BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6310582)

  • 21. Mutating the charged residues in the binding pocket of cellular retinoic acid-binding protein simultaneously reduces its binding affinity to retinoic acid and increases its thermostability.
    Zhang J; Liu ZP; Jones TA; Gierasch LM; Sambrook JF
    Proteins; 1992 Apr; 13(2):87-99. PubMed ID: 1377826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud.
    Maden M; Ong DE; Summerbell D; Chytil F
    Nature; 1988 Oct; 335(6192):733-5. PubMed ID: 2845280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166).
    Sugimoto T; Sawada T; Matsumura T; Horii Y; Kemshead JT; Suzuki Y; Okada M; Tagaya O; Hino T
    Cancer Res; 1987 Oct; 47(20):5433-8. PubMed ID: 2820569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression, purification, and binding properties of human cellular retinoic acid-binding protein type I and type II.
    Fogh K; Voorhees JJ; Aström A
    Arch Biochem Biophys; 1993 Feb; 300(2):751-5. PubMed ID: 8382035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid.
    Wei LN; Blaner WS; Goodman DS; Nguyen-Huu MC
    Mol Endocrinol; 1989 Mar; 3(3):454-63. PubMed ID: 2546063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
    Singh A; Rokes C; Gireud M; Fletcher S; Baumgartner J; Fuller G; Stewart J; Zage P; Gopalakrishnan V
    Cancer; 2011 Nov; 117(22):5189-202. PubMed ID: 21523764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of LA-N-5 neuroblastoma cells into cholinergic neurons: methods for differentiation, immunohistochemistry and reporter gene introduction.
    Hill DP; Robertson KA
    Brain Res Brain Res Protoc; 1998 Mar; 2(3):183-90. PubMed ID: 9507116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein.
    Giguère V; Lyn S; Yip P; Siu CH; Amin S
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6233-7. PubMed ID: 2166951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid-binding protein in human breast cancer and dysplasia.
    Huber PR; Geyer E; Küng W; Matter A; Torhorst J; Eppenberger U
    J Natl Cancer Inst; 1978 Dec; 61(6):1375-8. PubMed ID: 281544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue.
    Marshall GM; Cheung B; Stacey KP; Norris MD; Haber M
    Anticancer Res; 1994; 14(2A):437-41. PubMed ID: 8017844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha.
    Nagai J; Yazawa T; Okudela K; Kigasawa H; Kitamura H; Osaka H
    Cancer Res; 2004 Nov; 64(21):7910-7. PubMed ID: 15520197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
    Blaese MA; Santo-Hoeltje L; Rodemann HP
    Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRBP suppresses breast cancer cell survival and anchorage-independent growth.
    Kuppumbatti YS; Rexer B; Nakajo S; Nakaya K; Mira-y-Lopez R
    Oncogene; 2001 Nov; 20(50):7413-9. PubMed ID: 11704871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A; Zintl F
    Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential drug sensitivity of human neuroblastoma cells.
    Spengler BA; Ross RA; Biedler JL
    Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma.
    Gupta A; Williams BR; Hanash SM; Rawwas J
    Cancer Res; 2006 Aug; 66(16):8100-8. PubMed ID: 16912187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular retinoic acid binding protein: detection and quantitation in regenerating axolotl limbs.
    McCormick AM; Shubeita HE; Stocum DL
    J Exp Zool; 1988 Mar; 245(3):270-6. PubMed ID: 2838564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-binding protein in a human cell (MCF-7) from breast carcinoma.
    Takenawa T; Ueda H; Millan JC; Brandes D
    Lab Invest; 1980 May; 42(5):490-4. PubMed ID: 6247568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
    Clark RA; Newton M; Qiao J; Lee S; Chung DH
    Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytosolic retinoic acid-binding protein in human prostatic dysplasia and neoplasia.
    Jutley JK; Kelleher J; Whelan P; Mikel J
    Prostate; 1987; 11(2):127-32. PubMed ID: 2444952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.